Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 89

Sort by

Sort Order Select

Journal Articles

A modern view of LGL leukemia

Tony Marchand, Thierry Lamy, Thomas P. Loughran, Jr.

Blood (2024) 144 (18): 1910–1923.

https://doi.org/10.1182/blood.2023021790

Published: 2024

Journal Articles

Clinical Characteristics, Management, and Allogeneic Hematopoietic Cell Transplantation of Patients with Toll-like Receptor 8 Gain-of-Function Mutations

Danielle E Arnold, Saara Kaviany, Jahnavi Aluri, Luis Murguia-Favela, Nicola A. Wright, Thomas P. Loughran, Jr., Jonathan Powell, Suk See De Ravin, V. Koneti Rao, Steven Holland, Jack Bleesing, Jeffrey J. Bednarski, James A. Connelly, Megan Cooper

Blood (2023) 142 (Supplement 1): 936.

https://doi.org/10.1182/blood-2023-185110

Published: 2023

Journal Articles

Anti-Inflammatory Response to Anti-Folate and Vitamin D Analog Combination in Large Granular Lymphocyte Leukemia

Katie Moosic, Kristine Olson, David J Feith, Thomas P. Loughran, Jr.

Blood (2023) 142 (Supplement 1): 4194.

https://doi.org/10.1182/blood-2023-190063

Published: 2023

Journal Articles

The Final Results of a Phase I Study Using Bortezomib (Velcade), Cladribine, and Rituximab (VCR) in Treating Mantle Cell Lymphoma

Jeffrey J. Pu, Kristin Berger, Chunlei Zheng, Nhan V Do, David F. Claxton, W Christopher Ehmann, Joseph J. Drabick, Thomas P. Loughran, Jr., Elliot Epner

Blood (2023) 142 (Supplement 1): 6152.

https://doi.org/10.1182/blood-2023-185797

Published: 2023

Journal Articles

Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients

Blood (2023) 141 (9): 1036–1046.

https://doi.org/10.1182/blood.2021013489

Published: 2023

Includes: Supplemental data

Journal Articles

DR-01, a Non-Fucosylated Anti-CD94 Antibody, Depletes Leukemic Cells in Ex Vivo and In Vivo Models of Large Granular Lymphocyte Leukemia

Kelly Shi, Cindy Tan, Lu Bai, Jennifer Richardson, Andy Deng, Matthias Will, Michael Brehm, Dale Greiner, Leonard Shultz, Antonella Teramo, Renato Zambello, David J Feith, Thomas P. Loughran, Jr., Nenad Tomasevic

Blood (2022) 140 (Supplement 1): 2259–2260.

https://doi.org/10.1182/blood-2022-159242

Published: 2022

Journal Articles

Presence of Activating STAT3 Mutations in the CD8+ T Cells of Rheumatoid Arthritis Patients

Katharine B. Moosic, Thomas L. Olson, Mark Freijat, Samara Khalique, Cait E. Hamele, Bryna Shemo, Jesse Boodoo, William Baker, Matthew W. Schmachtenberg, Erika Darrah, Felipe Andrade, Kristine C. Olson, David J. Feith, Donald L. Kimpel, Thomas P. Loughran, Jr.

Blood (2022) 140 (Supplement 1): 11192–11193.

https://doi.org/10.1182/blood-2022-168069

Published: 2022

Journal Articles

Tolinapant, a Non-Peptidomimetic Antagonist of Inhibitors of Apoptosis Proteins, cIAP1/2 and XIAP, in Combination with the Hypomethylating Agents, Azacytidine and Decitabine Are Highly Synergistic in in Vitro Models of T Cell Lymphoma

John Sanil Manavalan, Ipsita Pal, Aidan Pursley, George A. Ward, Tomoko Smyth, Martin Sims, Jason A. Taylor, David J Feith, Thomas P. Loughran, Jr., Owen A. O'Connor, Enrica Marchi

Blood (2022) 140 (Supplement 1): 11552–11553.

https://doi.org/10.1182/blood-2022-169906

Published: 2022

Journal Articles

The Novel Nano-Formulation of the HDAC Inhibitor, Romidepsin, for the Treatment of Relapsed, Refractory Peripheral T-Cell Lymphoma

Ipsita Pal, Anuradha Illendula, John Sanil Manavalan, Todd P Fox, Owen A. O'Connor, Thomas P. Loughran, Jr., Mark Kester, David J Feith, Enrica Marchi

Blood (2022) 140 (Supplement 1): 8848–8849.

https://doi.org/10.1182/blood-2022-167628

Published: 2022

Journal Articles

Genomic landscape of TCRαβ and TCRγδ T-large granular lymphocyte leukemia

HeeJin Cheon, Jeffrey C. Xing, Katharine B. Moosic, Johnson Ung, Vivian W. Chan, David S. Chung, Mariella F. Toro, Omar Elghawy, John S. Wang, Cait E. Hamele, Ross C. Hardison, Thomas L. Olson, Su-Fern Tan, David J. Feith, Aakrosh Ratan, Thomas P. Loughran, Jr

Blood (2022) 139 (20): 3058–3072.

https://doi.org/10.1182/blood.2021013164

Published: 2022

Includes: Supplemental data

Journal Articles

Synergistic Role of Leukemic and Non-Leukemic Immune Repertoires in CD8+ T-Cell Large Granular Lymphocytic Leukemia As Identified By Single-Cell Transcriptomics

Blood (2021) 138 (Supplement 1): 1318.

https://doi.org/10.1182/blood-2021-146539

Published: 2021

Journal Articles

Tolinapant (ASTX660), a Non-Peptidomimetic Antagonist of cIAP1/2 and XIAP, and the HDAC Inhibitor Romidepsin Are Synergistic in in Vitro Models of T Cell Lymphoma

John S Manavalan, Ipsita Pal, Aidan Pursley, George A. Ward, Tomoko Smyth, Martin Sims, David J Feith, Thomas P. Loughran, Jr., Owen A. O'Connor, Enrica Marchi

Blood (2021) 138 (Supplement 1): 4356.

https://doi.org/10.1182/blood-2021-153451

Published: 2021

Journal Articles

Manifestation of Large Granular Lymphocyte Leukemia in Pediatric and Young Adult Population Is Distinct from Older Adult Cohorts

Heejin Cheon, Vivian Chan, Farid Ghamsari, Omar Elghawy, John Wang, David J Feith, Aakrosh Ratan, Thomas P. Loughran, Jr.

Blood (2021) 138 (Supplement 1): 2464.

https://doi.org/10.1182/blood-2021-151172

Published: 2021

Journal Articles

Frequent somatic TET2 mutations in chronic NK-LGL leukemia with distinct patterns of cytopenias

Thomas L. Olson, HeeJin Cheon, Jeffrey C. Xing, Kristine C. Olson, Umadevi Paila, Cait E. Hamele, Yaseswini Neelamraju, Bryna C. Shemo, Matt Schmachtenberg, Shriram K. Sundararaman, Mariella F. Toro, Cheryl A. Keller, Emily A. Farber, Suna Onengut-Gumuscu, Francine E. Garrett-Bakelman, Ross C. Hardison, David J. Feith, Aakrosh Ratan, Thomas P. Loughran, Jr

Blood (2021) 138 (8): 662–673.

https://doi.org/10.1182/blood.2020005831

Published: 2021

Includes: Supplemental data

Journal Articles

Recurrent Mutations of the C-C Motif Chemokine Ligand 22 ( CCL22 ) Define a Distinct Subgroup of Chronic Lymphoproliferative Disorder of NK Cells (CLPD-NK)

Constance Baer, PhD, Shunsuke Kimura, Ilaria Iacobucci, David J Feith, BS, PhD, Wencke Walter, PhD, Manja Meggendorfer, PhD, Thomas L. Olson, PhD, Aakrosh Ratan, PhD, Martha-Lena Müller, PhD, Mitra Rana, Chunxu Qu, PhD, Ravi Kalathur, Claudia Haferlach, MD, Wolfgang Kern, MD, Thomas P. Loughran, Jr., MD, Charles G Mullighan, MBBS, MD, Torsten Haferlach, MD

Blood (2020) 136 (Supplement 1): 19.

https://doi.org/10.1182/blood-2020-140695

Published: 2020

Journal Articles

Analysis of Genomic Landscape of Large Granular Lymphocyte Leukemia Reveals Etiologic Insights

HeeJin Cheon, BSc, Jeffrey C Xing, BS, David S Chung, BS, Mariella F Toro, BA, Cait E Hamele, BS, Thomas L. Olson, PhD, David J Feith, PhD, Aakrosh Ratan, PhD, Thomas P. Loughran, Jr., MD

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-137269

Published: 2020

Journal Articles

GDF1 Is a Regulator of Sphingolipid Metabolism in Acute Myeloid Leukemia

Weiyuan Wang, Emily Sullivan, Vasiliki Papakotsi, Andrea Cote, Paul Toran, PhD, Thomas P Loughran, Jr., MD, Brian Barth, PhD MS, BS

Blood (2019) 134 (Supplement_1): 1245.

https://doi.org/10.1182/blood-2019-130964

Published: 2019

Journal Articles

Blockade of IL-15 Utilizing Bnz-1, a Selective γ-Chain Inhibiting Peptide, Is Safe and Has Clinical Activity in Patients with T-Cell Large Granular Lymphocytic Leukemia (T-LGLL): Results of a Phase I/II Multi-Center Clinical Trial

Jonathan E. Brammer, MD, Lubomir Sokol, MD PhD, Yutaka Tagaya, MD PhD, Kerry Rogers, Anjali Mishra, PhD, Thomas A. Waldmann, MD, Nazli Azimi, PhD PharmD, Paul Frohna, MD PhD PharmD, Anoshie Ratnayake, MD, Thomas P Loughran, Jr., MD, Karen Ballen, MD

Blood (2019) 134 (Supplement_1): 2835.

https://doi.org/10.1182/blood-2019-129291

Published: 2019

Journal Articles

GDF1 Regulation of Ceramide Metabolism Restores Effective Hematopoiesis in Myelodysplastic Syndrome

Brian Barth, PhD MS, BS, Weiyuan Wang, Emily Sullivan, Vasiliki Papakotsi, Andrea Cote, Paul Toran, PhD, Sarah Walker, PhD, Thomas P Loughran, Jr., MD

Blood (2019) 134 (Supplement_1): 1700.

https://doi.org/10.1182/blood-2019-131623

Published: 2019

Journal Articles

TRAIL mediates and sustains constitutive NF-κB activation in LGL leukemia

Jun Yang, Francis R. LeBlanc, Shubha A. Dighe, Cait E. Hamele, Thomas L. Olson, David J. Feith, Thomas P. Loughran, Jr

Blood (2018) 131 (25): 2803–2815.

https://doi.org/10.1182/blood-2017-09-808816

Published: 2018

Includes: Supplemental data

NARROW

A modern view of LGL leukemia

Clinical Characteristics, Management, and Allogeneic Hematopoietic Cell Transplantation of Patients with Toll-like Receptor 8 Gain-of-Function Mutations

Anti-Inflammatory Response to Anti-Folate and Vitamin D Analog Combination in Large Granular Lymphocyte Leukemia

The Final Results of a Phase I Study Using Bortezomib (Velcade), Cladribine, and Rituximab (VCR) in Treating Mantle Cell Lymphoma

Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients

DR-01, a Non-Fucosylated Anti-CD94 Antibody, Depletes Leukemic Cells in Ex Vivo and In Vivo Models of Large Granular Lymphocyte Leukemia

Presence of Activating STAT3 Mutations in the CD8+ T Cells of Rheumatoid Arthritis Patients

Tolinapant, a Non-Peptidomimetic Antagonist of Inhibitors of Apoptosis Proteins, cIAP1/2 and XIAP, in Combination with the Hypomethylating Agents, Azacytidine and Decitabine Are Highly Synergistic in in Vitro Models of T Cell Lymphoma

The Novel Nano-Formulation of the HDAC Inhibitor, Romidepsin, for the Treatment of Relapsed, Refractory Peripheral T-Cell Lymphoma

Genomic landscape of TCRαβ and TCRγδ T-large granular lymphocyte leukemia

Synergistic Role of Leukemic and Non-Leukemic Immune Repertoires in CD8+ T-Cell Large Granular Lymphocytic Leukemia As Identified By Single-Cell Transcriptomics

Tolinapant (ASTX660), a Non-Peptidomimetic Antagonist of cIAP1/2 and XIAP, and the HDAC Inhibitor Romidepsin Are Synergistic in in Vitro Models of T Cell Lymphoma

Manifestation of Large Granular Lymphocyte Leukemia in Pediatric and Young Adult Population Is Distinct from Older Adult Cohorts

Frequent somatic TET2 mutations in chronic NK-LGL leukemia with distinct patterns of cytopenias

Recurrent Mutations of the C-C Motif Chemokine Ligand 22 ( CCL22 ) Define a Distinct Subgroup of Chronic Lymphoproliferative Disorder of NK Cells (CLPD-NK)

Analysis of Genomic Landscape of Large Granular Lymphocyte Leukemia Reveals Etiologic Insights

GDF1 Is a Regulator of Sphingolipid Metabolism in Acute Myeloid Leukemia

Blockade of IL-15 Utilizing Bnz-1, a Selective γ-Chain Inhibiting Peptide, Is Safe and Has Clinical Activity in Patients with T-Cell Large Granular Lymphocytic Leukemia (T-LGLL): Results of a Phase I/II Multi-Center Clinical Trial

GDF1 Regulation of Ceramide Metabolism Restores Effective Hematopoiesis in Myelodysplastic Syndrome

TRAIL mediates and sustains constitutive NF-κB activation in LGL leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only